Press Releases
- Aimmune Therapeutics Receives FDA Breakthrough Therapy Designation for AR101
- Hitachi High-Technologies and QIAGEN Enter Into Long-Term Strategic Collaboration for Molecular Testing
- Lumenis to be Acquired for Approximately $510 Million, $14.00 Per Share, in Cash
- 23andMe Genotypes One Millionth Customer
- Astellas And Medivation Announce Enrollment Of The First Patients In Advanced Prostate Cancer Outcomes Registry
- More Press Releases
Featured Jobs
> Need a job? Need to hire? Visit our jobs site.

